Lisata Therapeutics, Inc. (LSTA) stock
LSTANasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.28+0.08 (+6.67%)
Close on Nov 12, 2026Market cap $11.53MP/E –Yield –
Lisata Therapeutics ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Lisata Therapeutics's ebitda for the twelve months ending Jun 30, 2026 was -$16.36M. For fiscal 2025 it was -$18.06M. The highest annual figure on record is -$13.74M in fiscal 2010.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$18.06M | – |
| FY2024 | Dec 31, 2024 | -$22.24M | – |
| FY2023 | Dec 31, 2023 | -$25.52M | – |
| FY2022 | Dec 31, 2022 | -$57.53M | – |
| FY2021 | Dec 31, 2021 | -$29.00M | – |
| FY2020 | Dec 31, 2020 | -$19.08M | – |
| FY2019 | Dec 31, 2019 | -$19.99M | – |
| FY2018 | Dec 31, 2018 | -$16.79M | – |
| FY2017 | Dec 31, 2017 | -$27.19M | – |
| FY2016 | Dec 31, 2016 | -$29.00M | – |
| FY2015 | Dec 31, 2015 | -$111.75M | – |
| FY2014 | Dec 31, 2014 | -$56.14M | – |
| FY2013 | Dec 31, 2013 | -$35.81M | – |
| FY2012 | Dec 31, 2012 | -$29.39M | – |
| FY2011 | Dec 31, 2011 | -$32.56M | – |
| FY2010 | Dec 31, 2010 | -$13.74M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.99M | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.94M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.06M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.37M | – |
| Q2 FY2025 | Jun 30, 2025 | -$4.82M | – |
| Q1 FY2025 | Mar 31, 2025 | -$5.80M | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.91M | – |
| Q3 FY2024 | Sep 30, 2024 | -$5.29M | – |
| Q2 FY2024 | Jun 30, 2024 | -$5.48M | – |
| Q1 FY2024 | Mar 31, 2024 | -$6.56M | – |
| Q4 FY2023 | Dec 31, 2023 | -$5.98M | – |
| Q3 FY2023 | Sep 30, 2023 | -$5.92M | – |
| Q2 FY2023 | Jun 30, 2023 | -$6.83M | – |
| Q1 FY2023 | Mar 31, 2023 | -$6.80M | – |
| Q4 FY2022 | Dec 31, 2022 | -$6.49M | – |
| Q3 FY2022 | Sep 30, 2022 | -$37.71M | – |
| Q2 FY2022 | Jun 30, 2022 | -$6.71M | – |
| Q1 FY2022 | Mar 31, 2022 | -$6.61M | – |
| Q4 FY2021 | Dec 31, 2021 | -$6.84M | – |
| Q3 FY2021 | Sep 30, 2021 | -$6.95M | – |
| Q2 FY2021 | Jun 30, 2021 | -$7.13M | – |
| Q1 FY2021 | Mar 31, 2021 | -$8.07M | – |
| Q4 FY2020 | Dec 31, 2020 | -$5.43M | – |
| Q3 FY2020 | Sep 30, 2020 | -$5.33M | – |
| Q2 FY2020 | Jun 30, 2020 | -$4.28M | – |
| Q1 FY2020 | Mar 31, 2020 | -$4.04M | – |
| Q4 FY2019 | Dec 31, 2019 | -$5.03M | – |
| Q3 FY2019 | Sep 30, 2019 | -$5.06M | – |
| Q2 FY2019 | Jun 30, 2019 | -$5.33M | – |
| Q1 FY2019 | Mar 31, 2019 | -$4.58M | – |
| Q4 FY2018 | Dec 31, 2018 | -$3.80M | – |
| Q3 FY2018 | Sep 30, 2018 | -$3.72M | – |
| Q2 FY2018 | Jun 30, 2018 | -$4.19M | – |
| Q1 FY2018 | Mar 31, 2018 | -$5.07M | – |
| Q4 FY2017 | Dec 31, 2017 | -$7.20M | – |
| Q3 FY2017 | Sep 30, 2017 | -$6.04M | – |
| Q2 FY2017 | Jun 30, 2017 | -$7.62M | – |
| Q1 FY2017 | Mar 31, 2017 | -$6.33M | – |
| Q4 FY2016 | Dec 31, 2016 | -$5.34M | – |
| Q3 FY2016 | Sep 30, 2016 | -$5.63M | – |
See a number that looks wrong?